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Abstract
Introduction: In vivo pH imaging has been a field of interest for molecular imaging for many years. This is especially
important for determining tumor acidity, an important driving force of tumor invasion and metastasis formation, but also in
the process of apoptosis.
Methods: 2-(4-[
123I]iodophenethyl)-2-methylmalonic acid (IPMM), 2-(4-[
123I]iodophenethyl)-malonic acid (IPM), 2-(4-
[
123I]iodobenzyl)-malonic acid (IBMM) and 4-[
123I]iodophthalic acid (IP) were radiolabeled via the Cu
+ isotopic nucleophilic
exchange method. All tracers were tested in vitro in buffer systems to assess pH driven cell uptake. In vivo biodistribution of
[
123I]IPMM and [
123I]IPM was determined in healthy mice and the pH targeting efficacy in vivo of [
123I]IPM was evaluated in
an anti-Fas monoclonal antibody (mAb) apoptosis model. In addition a mouse RIF-1 tumor model was explored in which
tumor pH was decreased from 7.0 to 6.5 by means of induction of hyperglycemia in combination with administration of
meta-iodobenzylguanidine.
Results: Radiosynthesis resulted in 15–20% for iodo-bromo exchange and 50–60% yield for iodo-iodo exchange while in
vitro experiments showed a pH-sensitive uptake for all tracers. Shelf-life stability and in vivo stability was excellent for all
tracers. [
123I]IPMM and [
123I]IPM showed a moderately fast predominantly biliary clearance while a high retention was
observed in blood. The biodistribution profile of [
123I]IPM was found to be most favorable in view of pH-specific imaging.
[
123I]IPM showed a clear pH-related uptake pattern in the RIF-1 tumor model.
Conclusion: Iodine-123 labeled malonic acid derivates such as [
123I]IPM show a clearly pH dependent uptake in tumor cells
both in vitro and in vivo which allows to visualize regional acidosis. However, these compounds are not suitable for
detection of apoptosis due to a poor acidosis effect.
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Introduction
In contrast to normal tissue, solid tumors commonly have a high
metabolic rate and poor perfusion [1]. The elevated anaerobic
glycolysis in tumors frequently results in an extracellular acidifi-
cation [2,3,4]. Due to the poor perfusion, this increased
extracellular acidity is not washed away by the blood flow, and
an intratumoral acidic pH is created. This process was first
described by Warburg and is currently known as ‘the Warburg
effect’ [5]. Although various alternative pathways have been
proposed, including deficiencies in tumor perfusion, metabolic
abnormalities associated with transformation, and an increased
capacity for transmembrane pH regulation, that each contribute
to the intratumoral acidity, the general principle was shown to
hold true. Tumor acidity meanwhile has been linked to increased
invasion and metastasis formation, partly through hypoxia
inducible factor 1 (HIF-1) but also independently. It can therefore
be regarded as a prognostic factor for patient survival [6]. In
addition, together with poor perfusion and hypoxia, tumor acidity
as a physiological factor has a significant impact on the uptake of
chemotherapeutics in cancer cells [7]. Weakly basic chemother-
apeutic drugs, such as anthracyclines, anthraquinones and vinca
alkaloids, are assumed to accumulate in the (intracellular) acidic
sections of the cancer cell. The uptake of these compounds can be
diminished if the extracellular pH (pHe) is decreased. Conversely,
the uptake of acidic chemotherapeutic drugs is likely to increase in
conditions of lower pHe. Attempts were made to modulate pHe in
order to facilitate uptake of chemotherapeutic drugs, unfortunately
with only moderate success [8]. For example, Raghunand and
Robey both showed that increasing intratumoral pH in a
preclinical model by means of simple oral administration of
sodium bicarbonate led to a decreased number of metastasis
[9,10,11]. On the other hand, Jahde et al. showed in 1992 that a
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ecombination of hyperglycemia and a single administration of
meta-iodobenzylguanidine (MIBG) significantly decreased intra-
tumoral pHe from 6.9 to 6.2 [12]. However, this drastic
acidification had no significant impact on cell survival.
Therefore, molecular imaging of tumor acidity may provide
information on tumor prognosis but also provide insight in
treatment efficacy [13]). This has therefore been of interest for
many oncologists, although with only minor translation into the
clinic so far. Several magnetic resonance imaging (MRI)-based
methods for estimation of pHe in animal tumor models have
been introduced in recent years. These approaches include the
use of T1-weighted MRI with contrast agents that exhibit pH-
dependent
1H relaxation enhancement,
1H and
31P pH-
dependent chemical shift measurements, and
13C chemical shift
imaging of hyperpolarized
13C-labeled bicarbonate
[14,15,16,17,18]. At present, however, these techniques cannot
be readily translated to the clinic. In the early eighties of last
century
11C-labeled tracers were developed for PET that relied
on ion trapping to visualize brain tumors as well as brain pH in
general. It was found that solid brain tumors were not
significantly more acidic than the healthy brain, so could not
be readily visualized [19,20,21]. More recently, Vavere et al.
developed a pH-sensitive probe that showed high uptake in
LNCaP and PC-3 tumors, with higher uptake and retention in
the more acidic LNCaP tumors [7]. This uptake correlated with
differences in the bulk pHe of PC-3 and LNCaP tumors
measured in magnetic resonance spectroscopy experiments.
In a different approach,
18F-labeled 2-(5-fluoropentyl)-2-
methylmalonic acid (
18F-ML-10) was recently developed as an
apoptosis tracer [22,23]. The rationale is that, when undergoing
apoptosis, cells drastically lower their pHe, resulting in a specific
uptake of
18F-ML-10 in apoptotic cells by cell membrane
penetration, allowing to visualize apoptosis in vivo. The tracer
has excellent imaging qualities as it is cleared very rapidly from
the body, however its sensitivity for apoptosis imaging in vivo has
to be elucidated further since only low absolute uptake in
apoptotic cells is observed. It may be assumed that cell
membrane penetration can be facilitated by making the
moderately lipophilic tail on the malonic acid moiety of
18F-
ML-10 even more lipophilic. The malonic acid moiety itself
remains the same, leaving the highest pKa of such a compound
roughly identical (pKa =5.7860.05).
In this study, we designed several radiolabeled lipophilic
malonic acid derivates and evaluated these as pH-sensitive tracers
for SPECT imaging. Figure 1 shows the compounds we evaluated
as well as the charge distribution of one of the investigated
compounds at pH 6 and 7. To our knowledge, this is the first
paper that describes the synthesis, radiosynthesis and pH-
sensitivity of iodinated compounds suitable for SPECT.
Materials and Methods
All chemicals used were of analytical or pharmaceutical grade
and were purchased from Sigma-Aldrich, Acros Organics or
Fluka. Analytical grade 2-(4-bromobenzyl)-2-methylmalonic acid
(BrBMM) and 4-bromo-phthalic acid were purchased from AB
Chem and TCI Europe, respectively. For radiolabeling studies
sodium [
123I]iodide in 10
22 M NaOH (GE Healthcare) was used.
Identification of the synthesized products was achieved with
time-of-flight mass spectrometry (TOF-MS) (LCT, Micromass),
with an orthogonal electrospray ionization (ESI) interface.
Registration and analysis of the spectra were performed with
Masslynx software (version 3.5, Micromass). Radioactivity was
measured using an ionization chamber based activity meter
(Capintec Radioisotope Calibrator CRC-721) or an automated
NaI(Tl) gamma counter (Wallac Wizard). HPLC analyses were
performed using an LC apparatus that consisted of a solvent
pump (Hitachi Lachrom Elite L-2130 quaternary gradient
pump, VWR), a Platinum EPS-C18 column (5 mm,
10 mm6150 mm) (Grace-Alltech), a UV detector (Hitachi L-
2400 UV detector) at 254 nm and a 3-inch radiometric NaI(Tl)
detector in series.
Mobile phases at a flow rate of 3 ml/min: Method 1: 0.1%
trifluoroacetic acid (TFA) in water for 3 min, then linear gradient
to 0.1% TFA in acetonitrile (ACN) over the course of 17 minutes.
Method 2: 0.1% TFA in water (A) for 3 min, then linear gradient to
100% ethanol over 17 min.
1H-NMR spectra were recorded on a Bruker 400 MHz
spectrometer. Chemical shifts are reported in parts per million
(ppm) relative to tetramethylsilane (d =0). Coupling constants are
reported in hertz (Hz). Splitting patterns are defined by s (singlet),
d (doublet), t (triplet) and m (multiplet).
Synthesis of Precursors
2-(4-Iodophenyl)ethanol (1). 2-(4-Iodophenyl)ethanol was
prepared as described in the literature [24].
1-Iodo-4-(2-bromoethyl)benzene (2). 1-Iodo-4-(2-bro-
moethyl)benzene was also synthesized following a described
procedure [25].
2-(4-Iodophenethyl)-malonic acid diethyl ester (3). To a
solution of sodium (0.116 g, 5.06 mmol) in EtOH (5 ml) was
slowly added diethyl malonate (9.7 mmol, 1.56 g) and (2)
(0.746 g, 2.4 mmol) and the mixture was refluxed overnight.
After evaporation of the solvent under reduced pressure, the
residue was suspended in water and the mixture extracted with
EtOAc (2 x 50 ml). The organic layer was washed with 0.5 M HCl
(25 ml) and brine (25 ml) and dried over MgSO4. After
evaporation of the solvent under reduced pressure, the residual
yellow oil was purified using silica gel column chromatography
with heptane:EtOAc (20:1, v/v) as eluent. The fractions contain-
ing pure 3 were collected and evaporated, yielding 2.08 g (89%) of
the desired compound MS (ES)+: m/z [C15H18IO4Na]
+: calcu-
lated: 413 Da; measured: 413 Da.
1H-NMR (CDCl3): d 1.26 (6H,
t, OCH2CH3), 2.17(2H, q, CH2CH2CH); 2.61 (2H, t,
CH2CH2CH); 3.30(1H, t, CH2CH), 4.19(2H, q, OCH2CH3);
6,92 (2H, d, ArH); 7,36 (2H, d, ArH).
2-(4-Iodo-phenethyl) malonic acid (IPM, 4). A solution of
compound 3 (390 mg, 1 mmol) in a mixture of EtOH:H2O (1:1,
v/v) was refluxed for 30 minutes. The solvent was evaporated
under reduced pressure and 1 M HCl was added to adjust the pH
to 1.5. The mixture was stirred for 30 min at room temperature
(RT) and the formed precipitate filtered off, washed with water
and dried in a vacuum oven at 60uC to yield 225 mg (58%) of a
white product. MS (ES)
-: m/z [C15H19IO4]
-: calculated: 332 Da;
measured: 332 Da.
1H-NMR (CDCl3): d 2,78 (2H, t,
CH2CH2OH); 3,80 (2H, t, CH2CH2OH); 6,96 (2H, d, ArH);
7,61 (2H, d, ArH). HPLC analysis using method 1 showed a single
peak with a Rt of 14.2 min.
2-(4-Iodophenethyl)-2-methyl-malonic acid (IPMM)
(6). The synthesis of IPMM was analogous to that of IPM,
starting from 2-methyl malonic acid diethyl ester instead of
malonic acid diethyl ester, resulting in 2-(4-iodophenethyl)-2-
methyl-malonic acid (6). The yield was comparable (slightly lower)
when compared to that of IPM. MS (ES)
-: m/z [C12H12IO4]
--
Calculated: 346 Da; m/z [C12H12IO4]
-Sample :346 Da. HPLC
analysis using method 1 showed a single peak with a Rt of
15.2 min.
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All radiotracers were prepared using a Cu
+ assisted labeling
method [26,27]. In a 1-ml septum-closed vial, 28 ml of an aqueous
CuSO4.5H2O solution (1.3610
22 mol/l) was added to a mixture
of precursor (1 mg dissolved in 20 ml EtOH), SnSO4 (1 mg,
4.5 mmol), gentisic acid (1.25 mg, 6.4 mmol) and citric acid
(2.5 mg, 4.7 mmol) in 0.5 ml H2O. This solution was flushed with
N2 for 10 min and 37–185 MBq no carrier added sodium
[
123I]iodide in 10
22 M NaOH was added. The reaction vial was
heated at 90uC for 60 min and the reaction product was purified
using HPLC (method 2). The peak with the purified radiolabeled
compound was collected and diluted with 200 ml 0.5 M phosphate
buffer (pH 7). The mixture was heated at 70uC under a stream of
nitrogen to evaporate the ethanol. The solution was diluted to
1 ml with normal saline and finally passed over a sterile 0.22-mm
filter.
Different reaction conditions were tested. Precursor concentra-
tion was varied (0.5, 1 and 2 mg) as well as reaction time (10, 20,
40, 50, 60, 70, 80 and 90 min). Reaction temperature was kept
constant at 90uC.
In vitro Experiments
To study pH driven uptake of the iodine-123 labeled tracers,
their uptake in cells dying through apoptosis or necrosis and in
cells in a potassium-rich medium was determined as previously
described [28]. In short, apoptosis was induced by addition to
the medium of monoclonal anti-Fas antibody, while necrosis
was induced by submitting the cells to three freeze-thaw cycles.
In addition, the uptake of [
123I]IPM was evaluated in phosphate
buffered solutions, in either saline solution (140 mM NaCl) or a
potassium solution (140 mM KCl instead of NaCl), where the
pH was varied (ranging from 5.5 to 7.5 in 0.5-unit increments).
Tracer uptake was plotted against the in situ pH value.
In vivo Stability, Biodistribution and pH-dependency
All animal experiments were conducted according to the
Belgian code of practice for the care and use of animals, after
approval from the KULeuven university ethics committee for
animals. Shelf-life stability of the radiolabeled compounds was
studied with RP-HPLC, using method 2. After sample
preparation, in vitro and in vivo plasma stability was also studied
by RP-HPLC. Sample preparation consisted of protein precip-
itation by addition of acetonitrile and subsequent filtration. The
biodistribution of radioiodinated IPMM and IPM was studied in
healthy NMRI mice. Radiolabeled IBMM and IP were not
further investigated at this point, due to their poor radiolabeling
yields. Male NMRI mice were injected intravenously (i.v.) under
isoflurane anesthesia with 370 kBq of radiolabeled compound (n
$3 per compound). SPECT imaging (E-cam, Siemens Medical
Systems) was performed in healthy mice 45–80 min p.i. of
15 MBq [
123I]IPM, while CT images were acquired using a
Hirez CT scanner (Siemens). In a first attempt to study the pH-
dependent uptake of [
123I]IPM, NMRI mice were administered
intravenously 0.1 mg/g (group 1) or 0.2 mg/g (group 2) anti-Fas
monoclonal antibody (mAb; Jo2, BD Pharmingen), 90 min prior
to i.v. administration of [
123I]IPM. The anti-Fas mAb induces
massive hepatic apoptosis, as well as minor levels of apoptosis in
Figure 1. Charge distribution of 2-(4-iodo-phenethyl)-malonic acid (IPM) at pH 7 (2 negative charges) and at pH 6 (the compound
contains only one negative charge, which is distributed over the malonate moiety). Given that the highest pKa value for IPM is 5.78, a
significant portion of the compound is in this state at pH 6, allowing passive diffusion over a cell membrane. The lower part of the figure depicts the
structure of 2-(4-iodo-phenethyl)-malonic acid (IPM), 2-(4-iodo-phenethyl)-2-methyl-malonic acid (IPMM), 2-(4-iodo-benzyl)-2-methyl-malonic acid
(IBMM) and 4-iodo-phtalic acid (IP).
doi:10.1371/journal.pone.0038428.g001
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decapitation under anesthesia at 60min p.i. of the radiotracer
parts of the liver were fixed in 6% formaldehyde for paraffin
embedding and histological studies. Five-micrometer sections
were cut from paraffin embedded livers for histological staining.
In a second experiment, the uptake of [
123I]IPM in RIF-1
tumor bearing syngeneic C3H/HeNCrl mice was determined in
two conditions. The uptake was first determined in healthy
untreated tumor-bearing animals. Secondly, the tumor uptake was
studied in animals that were treated with a cocktail of glucose (two
injections at 5 min and 60 min prior to tracer injection, 3 mg/g
body weight, i.p.,) and MIBG (30 mg/g body weight, i.p., 60 min
prior to tracer injection) to lower intratumoral pH. A micro pH
electrode (Lazar Research Laboratories, Los Angeles, USA) was
used to monitor intratumoral pH.
In all experiments the mice were sacrificed by an overdose of
Nembutal 60 min post injection (p.i.) of the tracer. The activity of
the weighed organs was measured to calculate the percentage of
ID (% ID) and % ID/organ weight (%ID/g). Part of the healthy
liver, the apoptotic liver and tumor tissue was frozen for
autoradiography as previously described (20) and the other part
fixed in 6% formaldehyde for paraffin embedding. From paraffin
embedded tissues 5-mm sections were cut for standard hematoxylin
and eosin (H&E) staining and caspase-3 staining.
Data Analysis
Image analysis was performed with PMOD software (version
3.1; PMOD Inc.). All data are expressed as mean 6 SEM, with n
=3 or more unless mentioned otherwise. GraphPad Prism
(GraphPad) was used for statistical analysis of group results using
ANOVA, as well as determining goodness of fit (r
2, using
Spearman rank test).
Results
Synthesis and Radiosynthesis
The precursor compounds were synthesized in a moderate but
sufficient yield. Their identity was confirmed by MS and
1H-
NMR.
Radioiodination of 2-(4-bromobenzyl)-2-methylmalonic acid
and 4-bromophthalic acid by nucleophilic exchange resulted in a
maximal yield of 15–20%. IPM and IPMM were radioiodinated
by isotopic nucleophilic exchange with a maximal yield of 60%.
Precursor amount (in the range 0.5–2 mg) did not have impact on
this result, and a maximal yield was obtained after 40 min reaction
time at 90uC. The remaining 40% of the radioactivity was
associated with an unidentified side product that was quickly
formed (within 10 min of heating), but easily separated from
123I-
labeled IPM or IPMM on HPLC (figure 2). The percentage of
iodine-123 in the form of iodide was below 3% in optimal labeling
conditions. HPLC purification allowed for the collection of pure
123I-labeled IBMM, IP, IPM and IPMM (retention times
respectively 14.5, 13.5, 14.5 and 15.0 min) in a volume of
maximum 3 ml (1 min collection). Separation of brominated from
iodinated compound was not attempted. After addition of 200 ml
0.5 M phosphate buffer (pH 7), subsequent evaporation did not
affect compound stability and allowed to obtain the pure
compound in an ethanol-free solution.
In vitro Evaluation
Figure 3 shows the uptake of
123I-labeled IPMM, IBMM, IP
and IPM in different conditions. Increased uptake of all tracers
was observed in apoptotic cells and cells incubated in KCl-
phosphate buffer (PB) medium compared to NaCl-phosphate
buffer control conditions. In comparison to apoptotic cells, cells in
KCl-PB showed the most pronounced uptake. No increased
uptake was observed in cells undergoing necrosis. No significant in
situ pH decrease was noticed in any of the conditions, except for
cells in a KCl-PB medium where pH decreased by about 0.5 pH
units.
Although the absolute uptake of the tracer showed significant
differences, the ratios of uptake in apoptotic cells versus control
cells ranged from 1.4 (for 4-iodophthalic acid) to 1.8 (for IPMM).
The ratios of uptake in KCl-PB incubated cells vs. cells in control
conditions ranged from 2.3 (for IP) to 5.7 (for IPMM). The effect
of KCl on the uptake of [
123I]IPM as a function of pH is illustrated
in figure 4. It is clear that the KCl-PB solution lead to more acidic
in situ pH values, correlating with an increased uptake of
123I-
labeled IPM at pH values below 6.5. However, even at identical in
situ pH, the uptake of [
123I]IPM in a KCl-PB was higher
compared to that in a NaCl-PB, indicating that in addition to the
pH effect KCl also increased tracer uptake via another pathway,
namely the described plasma membrane depolarization [23]. The
uptake of [
123I]IPM in Jurkat cells was linearly correlated with the
ratio of [IPM
-]/[IPM
22]( r
2.0.95).
In vivo Evaluation
After i.v. injection of
123I-labeled IPMM and IPM in healthy
mice, analysis of plasma and urine samples at 60 min p.i. did not
reveal any radioactive metabolites as shown by HPLC analysis.
The biodistribution of
123I-labeled IPMM and IPM in healthy
mice at 60 min p.i. is shown in figure 5. Both compounds are
slowly cleared renally (respectively 33.669.9 and 19.067.1%ID in
the urine at 60 min p.i.). The biodistribution pattern is roughly
similar for both compounds, including a high blood pool retention
and high activity in all highly perfused organs. Figure 6 shows a
SPECT/CT image of the biodistribution of [
123I]IPM in a NMRI
mouse acquired between 45–80 minutes p.i. The activity in the
bladder and the blood pool can easily be observed, while the tracer
is uniformly distributed.
In the anti-Fas mAb treated mice, the degree of apoptosis was
strongly dependent on the administered dose of anti-Fas mAb: 15–
30% of hepatic cells were apoptotic in the group that received
0.1 mg/g, while 85–95% of hepatic cells were apoptotic in the
group that received 0.2 mg/g. [
123I]IPM hepatic uptake in anti-Fas
mAb treated mice, when compared to hepatic uptake in control
conditions, did not increase in the 0.1 mg/g group but increased in
the 0.2 mg/g group, although not significantly (p =0.18). There
was no linear correlation between the degree of hepatic apoptosis
and hepatic uptake of [
123I]IPM (r
2=0.476). No pH decrease was
noticed in the liver of any of the models. No increased uptake in
the spleen or lungs was noticed for any tracer.
The biodistribution of [
123I]IPM in RIF-1 tumor bearing C3H/
Henkel mice was similar to that in NMRI mice, with tumor uptake
in normal conditions amounting to 1.6460.21%ID/g. Glycemia
was 207657 mg/dl in these animals and intratumoral pH was
7.0560.12. In mice treated with a cocktail of glucose and MIBG
glycemia increased to 3566139 mg/dL and tumor pH decreased
to 6.5760.18, whereas pH of liver and muscle remained
unchanged. No increase in the extent of apoptotic cells in the
tumor was noticed. The uptake of [
123I]IPM in the more acidic
tumor was 3.8061.18 times higher than in the tumor of untreated
animals (p =0.003). Autoradiography (figure 7) confirmed a 3
times higher uptake in the more acidic tumor and showed regional
hot spots of activity in the tumor tissue.
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reaction time, 906C, 1 mg precursor). In the UV signal, gentisic acid (Rt: 10 min), IPMM (Rt: 15 min) and IPMM diethyl ester (Rt: 16 min) can be
identified. In the radiochromatogram,
123I-labeled IPMM and
123I-labeled IPMM diethyl ester can be seen, as well as an unidentified side compound
(Rt: 7 min).
doi:10.1371/journal.pone.0038428.g002
Figure 3. Uptake of
123I-labeled IPMM, IBMM, IP and IPM in Jurkat cells in control conditions, with anti-fas mAb induced apoptosis,
incubated in KCl-solution and with freeze-thaw induced necrosis.
doi:10.1371/journal.pone.0038428.g003
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The physiological differences between normal and diseased
tissues, especially tumor tissues, provide an opportunity for
development of specific diagnostic tracers. Especially the pH of
tumor tissue, if acidic, provides a strong prognostic factor for
metastasis formation and thus patient survival. However, the
intratumoral acidic environment has up to now not been
adequately exploited for imaging purposes. So far, few compounds
that show significant changes in properties, e.g. charge, in the pH
range between 6.0 and 7.5 have been developed and no clinical
data are available. Vavere et al. developed a
64Cu-labeled pH-
sensitive peptide that showed high uptake in LNCaP and PC-3
tumors, with higher uptake and retention in the more acidic
LNCaP tumors [7]. This compound is very promising and further
research is necessary to validate the tracer.
Inspired by the use of a
18F-labeled malonic acid analogue
for PET imaging of apoptosis in vivo [23], we developed in this
study new lipophilic radiolabeled malonic acid analogues for
imaging pH differences using SPECT. Malonic acid has pKa
values of 2.83 and 5.69, while 2-methylmalonic acid has pKa
values of 3.07 and 5.78. This means that, as soon as the
Figure 4. Uptake of
123I-labeled IPM in Jurkat cells after 3 h incubation in phosphate buffered NaCl or phosphate buffered KCl
solutions as a function of in situ pH. The [IPM
2/[IPM
22] ratio is shown for comparison (dotted line).
doi:10.1371/journal.pone.0038428.g004
Figure 5. Biodistribution of
123I-labeled IPMM and IPM in healthy NMRI mice, 60 min p.i.
doi:10.1371/journal.pone.0038428.g005
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compound has a net charge of 21, which is shared throughout
the malonic acid moiety by a hydrogen-bridge between the two
carboxyl functions [23].
In these conditions, malonic acid and its derivatives are
lipophilic enough to be transported through the cell membrane.
Once inside, the higher intracellular pH further deprotonates the
malonic acid moiety, resulting in a net charge of 22, rendering the
compound unable to rediffuse across the membrane.
We successfully synthesized IPMM and IPM. Radiosynthesis of
123I-labeled IPMM and IPM using Cu
+ catalyzed isotopic
exchange was optimized, with a final yield of 60%. Radiosynthesis
of
123I-labeled IBMM and IP, starting from brominated precur-
sors, was achieved with a yield of 15–20%. Considering the better
properties of an iodo substituent as a leaving group, such yields are
in the range of expectance. Unfortunately, radioiodine for iodine
substitution does not allow radiosynthesis with a high specific
activity (expressed in MBq/mmol compound). Although specific
activity may not be important in pH-driven membrane crossing, it
may be advantageous to use electrophilic substitution using a
tributyl or trimethyl stannyl leaving group for future studies as they
do allow easy separation of precursor and radiolabeled compound.
The data from the in vitro experiments clearly demonstrate
that all four tracers show a higher uptake in an acidic
environment. The acidification caused by apoptosis in vitro is
limited (decrease of ,0.1 pH unit), causing only a 1.4–1.8 fold
increase in tracer uptake. On the other hand the stronger
acidification and plasma membrane depolarization caused by
KCl (.0.5 pH unit) resulted in a 2.3–5.7 fold increase in tracer
uptake. More detailed analysis showed that it is mainly the
acidification that causes increased tracer uptake. [
123I]-IP
showed the lowest increase in pH-related uptake, presumably
due to its lower pKa values when compared to 2-methylmalonic
acid (5.51 vs 5.78).
Due to the poor labeling yields (expressed as % radiolabeled
compound with respect to the starting amount of radioactivity,
non-decay corrected) when starting from brominated precursors,
only
123I-labeled IPMM and IPM were evaluated in vivo.
Biodistribution studies showed a high blood pool activity and
slow clearance for both compounds, with slightly lower blood pool
values for [
123I]IPM. This high blood pool activity probably results
from the high lipophilicity of the molecule which could potentially
hamper the use for in vivo molecular imaging and must be kept in
mind when further developing pH sensitive tracers. Apart from the
higher uptake in well perfused organs, no increased uptake was
noticed in any specific organ. Anti-Fas mAb induced hepatic
apoptosis did not correlate with a higher hepatic uptake of
[
123I]IPM. Most likely the decrease in pH as a result of apoptosis is
insufficient to allow a significant uptake of the tracer in vivo.
Nevertheless the increased hepatic uptake in the 0.2 mg/g group
can be related to a small pH decrease as a result of apoptosis
although it may also be explained by vascular disruption and
leakage due to apoptosis [30]. Taken together with the minor
uptake in apoptotic cells in vitro, this finding indicates that the
malonic acid derivates investigated in this study are not reliable as
apoptosis tracers in vivo.
Using a cocktail of MIBG and glucose, inducing tumor
acidosis by inhibiting the citric acid cycle (MIBG-induced) and
increasing glucose consumption (glucose-induced effect),
[
123I]IPM showed a 2.5-fold higher uptake in acidic tumors
(pH 6.57) as compared to normal tumors (pH 7.05). It can be
assumed that acid derivatives with a higher pKa value, such as
Figure 6. SPECT/CT image of [
123I]-labeled IPM in healthy NMRI mice, acquired between 45–80 min p.i. (summed image). (A) Coronal
section of the mouse body (head not included), showing high uptake in bladder and heart (blood pool). (B) Transversal section of the mouse in the
heart region. (C) Transversal section showing bladder activity.
doi:10.1371/journal.pone.0038428.g006
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even higher uptake in acidic tumors.In any case, pre-treatment
of subjects with MIBG is recommended to intensify tumor
uptake. MIBG has been used safely in the past, in experimental
studies as well as in clinical practice, as an attempt to treat
tumors by acidosis induction [12] but also as a radiolabeled
agent for molecular imaging (labeled with
123I) or even
treatment (labeled with
131I) of neuroblastoma [31,32,33].
Further studies are required to validate the usefulness of
[
123I]IPM, preferably comparing the uptake in metastasis forming
acidic tumors to that in lower grade tumors.
Conclusion
An early evaluation of cancer therapy by means of apoptosis
imaging is not possible with [
123I]IPM due to the low pH decrease
in apoptotic tissue.
123I-labeled malonic acid derivates, such as [
123I]IPM, do show
a clear pH dependent uptake in tumor cells both in vitro and in vivo
and can visualize regions of acidosis. If this can be applied in a
clinical setting, this would allow a vast improvement in the
assessment of tumor progression due to the strong link between
tumor acidosis and metastasis formation. If the sensitivity of
[
123I]IPM is further confirmed, this could make pH-sensitive
SPECT imaging a new factor in patient diagnosis, prognosis and
treatment planning.
Figure 7. pH dependency of tumor uptake. Autoradiographic images of tumor slices from untreated (A) and treated (B) (hyperglycemia + MIBG)
mice. (C) and (D) are caspase-3 stainings of respective tumor tissues. The table indicates pH, [IPM
-]/[IPM
22] ratio at indicated pH and the uptake of the
tracer, expressed as %ID/g.
doi:10.1371/journal.pone.0038428.g007
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